Mental Health in Austrian Teenagers (MHAT)

NCT03301077 | Completed

• 1 other identifier: FA765A0303
• Study Type: observational
• Target: 4,000
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of the Mental Health in Austrian Teenagers (MHAT) - Study is to collect the first epidemiological data on mental health and psychiatric disorders in a representative sample of Austrian adolescents between 10 and 18 years.

Conditions

Mental Disorders

Keywords

children and adolescents; mental health; epidemiology; psychiatric disorders

Outcome Measures

Primary Outcomes (1)

• psychiatric problems (diagnoses based on the Diagnostic and Statistical Manual of the American Psychiatric Association, Version 5 (DSM-5)

  Screening and interview

  12 months

Secondary Outcomes (3)

• rates of behavioral, emotional and social problems (representation of data collected at interview)

  12 months

• psychiatric disorder related risks and protective factors (representation of data collected at interviews)

  12 months

• quality of life (total score, self-perception, parent relation & home life, social support & peers, school environment and bullying)

  12 months

Study Arms (1)

General population

recruited from schools and other institutions like job-centers or child and adolescent psychiatries

Other: 2-phase epidemiological study (screening, interviews)

Interventions

2-phase epidemiological study (screening, interviews) OTHER

first phase is the screening phase, second phase is the interview phase

General population

Eligibility Criteria

• Age: 10 Years - 18 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64)
• Sampling Method: Probability Sample

Study Population

general population

You may qualify if:

• adolescents aged 10-18

You may not qualify if:

• no written informed consent possible due to intelligence or no willingness by parents to include minor

Sponsors & Collaborators

• Medical University of Vienna: lead
• Ludwig Boltzmann Institute Health Promotion Research: collaborator
• Pharmig - Gesundheitsziele aus dem Rahmen-Pharmavertrag: collaborator

Study Sites (1)

Medical University of Vienna, Dep. of Child and Adolescent Psychiatry

Vienna, 1090, Austria

Location

Related Links

• Related Info

MeSH Terms

Conditions

Mental Disorders; Psychological Well-Being

Interventions

Mass Screening; Interviews as Topic

Condition Hierarchy (Ancestors)

Personal Satisfaction; Behavior

Intervention Hierarchy (Ancestors)

Diagnostic Techniques and Procedures; Diagnosis; Health Surveys; Surveys and Questionnaires; Data Collection; Epidemiologic Methods; Investigative Techniques; Diagnostic Services; Preventive Health Services; Health Services; Health Care Facilities Workforce and Services; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health; Public Health Practice

Study Officials

• Andreas Karwautz, MD, Prof

  Medical University Vienna

  STUDY DIRECTOR

• Wolfgang Dür, Phd, Prof

  Ludwig Boltzmann Institute LBIHPR

  STUDY DIRECTOR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Univ. Prof. Dr.

Study Record Dates

• First Submitted: July 21, 2014
• First Posted: October 4, 2017
• Study Start: January 1, 2013
• Primary Completion: April 1, 2015
• Study Completion: April 1, 2015
• Last Updated: March 7, 2019

Record last verified: 2019-03

Locations

AU (1)